<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ArQule Inc. | Company News & Executive Profiles - ARQL | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/arqule+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for ArQule Inc.]]></description>
	<s:counts start="0" returned="10" found="20" />
	<language>en-us</language>
	<item>
		<title><![CDATA[ArQule, Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-361463.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from the line of Bret Holley with Oppenheimer. Please proceed. Jay &#8211; Oppenheimer Good morning. This is Jay [ph] calling in for Bret. I had a quick question on 197 in pancreatic cancer. And that is, given the positive indications you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 05 Nov 2009 10:44:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pancreas.html"><![CDATA[Pancreas]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/term.html"><![CDATA[Term]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-276208.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from the line of Mark Monane from Needham & Company. Please proceed. Mark Monane &#8211; Needham & Company Thank you, good morning, and thank you for the comprehensive review. Brian Schwartz Good morning. 	 Mark Monane &#8211; Needham & Company Glenn...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 05 Mar 2009 11:45:40 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/trial+design.html"><![CDATA[Trial Design]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule Joins Forces with Daiichi Sankyo to Fight Cancer]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105369-arqule-joins-forces-with-daiichi-sankyo-to-fight-cancer%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits:  ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development and discovery of novel oncology therapeutics. One agreement covers the license of ARQ 197 and the other is an R&D agreement.  ARQ...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 11 Nov 2008 08:13:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[Agreement]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/arq+197.html"><![CDATA[ARQ 197]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-248085.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. First question comes from the line of Mark Monane of Needham & Company.  Mark Monane - Needham & Company Thanks for taking our questions. Congratulations on your progress, a very exciting way to start the week. Peter Lawrence Thank you, Mark. Mark Monane -...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 10 Nov 2008 12:11:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/lung+cancer.html"><![CDATA[Lung Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/lung+cancer.html"><![CDATA[Lung Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule, Inc., Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224234.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions Your first question comes from the line of Mark Monane with Needham & Company. Please proceed. Mark Monane - Needham & Company Good morning and greetings from New York City. Thanks for taking our questions. Paolo Pucci Good morning. Mark Monane - Needham...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 Aug 2008 11:28:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule, Inc. to Present at BMO Capital Markets Focus on Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_29/ai_n27950575]]></link>
		<description><![CDATA[WOBURN, Mass. -- ArQule, Inc. (Nasdaq: ARQL) today announced that it will present at the BMO Capital Markets Focus on Healthcare Conference on Tuesday, August 5, 2008 at 10:45 a.m. eastern time.  ArQule's presentation will be web cast live and can be accessed through the investor relations section of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ARQL,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Data Presented at ASCO Identify Maximum Tolerated Dose and Confirm c-Met Inhibition in Tumors with ARQ 197, Under Development by ArQule]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_1/ai_n25470608]]></link>
		<description><![CDATA[CHICAGO -- Investigators today presented data from a Phase 1, dose-escalation trial with ARQ 197, a selective inhibitor of the c-Met receptor tyrosine kinase under development by ArQule, Inc. (NASDAQ: ARQL). These data demonstrate that the compound is safe and well tolerated at oral doses up to 300 milligrams mg...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[ArQule Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-227035.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Our first question comes from the line of from inaudible with Needham & Company. Unidentified Analyst Hi, good morning. This is inaudible from Needham & Company. My first question is clinical, in terms for ARQ 197 single agent versus combination trials, what do you think...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 12 May 2008 11:22:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[WPL, VKL, ARQL, CPLP, CRME, CROX Have Also Been Removed From Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25271756]]></link>
		<description><![CDATA[M2 PRESSWIRE-4 April 2008-BUYINS.NET: WPL, VKL, ARQL, CPLP, CRME,  CROX Have Also Been Removed From Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:04042008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been removed from the NASDAQ, AMEX and NYSE naked...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/crocs+inc..html"><![CDATA[Crocs Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CROX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ARQL,CROX,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[CRZ, USS, RAK, ARQL, ETFC, NPSP Have Been Added To Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25266502]]></link>
		<description><![CDATA[M2 PRESSWIRE-20 March 2008-BUYINS.NET: CRZ, USS, RAK, ARQL, ETFC,  NPSP Have Been Added To Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:20032008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked short...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 20 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/petroleum.html"><![CDATA[petroleum]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ARQL,NDAQ</category>
	</item>
</channel>
</rss>
